(Q81683808)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Hormone regulation of microglial cell activation: relevance to multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

1 reference

Paul D Drew

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Paul D Storer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Jihong Xu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Janet A Chavis

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

19 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

322-327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

Cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells

11 January 2020

cites work

1 reference

12 December 2020

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

12 December 2020

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

1 reference

12 December 2020

Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes

1 reference

12 December 2020

15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway

1 reference

12 December 2020

Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions

1 reference

12 December 2020

Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages

1 reference

12 December 2020

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

12 December 2020

Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells

1 reference

12 December 2020

Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Investigating chemokines and chemokine receptors in patients with multiple sclerosis: opportunities and challenges

1 reference

12 December 2020

Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells.

1 reference

12 December 2020

15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms.

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase

1 reference

12 December 2020

The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells

1 reference

12 December 2020

Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages

1 reference

12 December 2020

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

12 December 2020

Chemokines in autoimmune disease

1 reference

12 December 2020

Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor

1 reference

12 December 2020

Immunological aspects of demyelinating diseases

1 reference

12 December 2020

Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium

1 reference

12 December 2020

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

1 reference

12 December 2020

Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma

1 reference

12 December 2020

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

1 reference

12 December 2020

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis

1 reference

12 December 2020

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

12 December 2020

Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790

1 reference

12 December 2020

Apoptosis of inflammatory cells in immune control of the nervous system: role of glia

1 reference

12 December 2020

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

1 reference

12 December 2020

Cyclopentenone prostaglandins: new insights on biological activities and cellular targets

1 reference

12 December 2020

Hormonal factors in susceptibility to multiple sclerosis

1 reference

12 December 2020

PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression

1 reference

12 December 2020

Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2

1 reference

12 December 2020

Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons

1 reference

12 December 2020

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

12 December 2020

Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2.

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2.

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

1 reference

12 December 2020

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

12 December 2020

Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists

1 reference

12 December 2020

Effect of pioglitazone treatment in a patient with secondary multiple sclerosis

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation

1 reference

12 December 2020

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

1 reference

12 December 2020

The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis

1 reference

12 December 2020

The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses

1 reference

12 December 2020

Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro

1 reference

12 December 2020

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

1 reference

12 December 2020

10.1016/J.BRAINRESREV.2004.12.020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15850670%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

PubMed publication ID

15850670

1 reference